Malignant pleural mesothelioma: time for translational research-Reference-Cited by-同舟云学术

Malignant pleural mesothelioma: time for translational research

Published:2004-10 Issue:10 Volume:5 Page:591
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Cesario Alfredo,Russo Patrizia,Viaggi Silvia,Trombino Sonya,Imperatori Andrea,Margaritora Stefano,Dominioni Lorenzo,Festi Luigi,Porziella Venanzio,Granone Pierluigi

Publisher

Elsevier BV

Subject

Oncology

Reference7 articles.

1. Defective coreapoptosis signaling in diffuse malignant pleural mesothelioma: opportunities for effective drug development;Fennell;Lancet Oncol,2004

2. BCL-2 gene family and the regulation of programmed cell death;Korsmeyer;Cancer Res,1999

3. Mitotic mechanics: the auroras come into view;Andrews;Curr Opin Cell Biol,2003

4. High throughput testing of the SV40 large T antigen binding to cellular p53 identifies putative drugs for the treatment of SV40-related cancers;Carbone;Virology,2003

5. Induction of apoptosis in mesothelioma cells by antisurvivin oligonucleotides;Xia;Mol Cancer Ther,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neurotoxins Acting at Synaptic Sites: A Brief Review on Mechanisms and Clinical Applications;Toxins;2022-12-27

2. Cervical Cancer Correlates with the Differential Expression of Nicotinic Acetylcholine Receptors and Reveals Therapeutic Targets;Marine Drugs;2019-04-28

3. α-Conotoxin ImI-modified polymeric micelles as potential nanocarriers for targeted docetaxel delivery to α7-nAChR overexpressed non-small cell lung cancer;Drug Delivery;2018-01-01

4. The challenge of prognostic markers in pleural mesothelioma;J THORAC DIS;2013

5. Is ?7-nAChR a Possible Target for Lung Cancer and Malignant Pleural Mesothelioma Treatment?;Current Drug Targets;2012-04-23